Ergoteles’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-138,311
Closed -$13.8M 1171
2023
Q1
$13.8M Buy
138,311
+130,174
+1,600% +$13.2M 0.54% 33
2022
Q4
$806K Buy
8,137
+735
+10% +$71.4K 0.03% 536
2022
Q3
$649K Sell
7,402
-1,497
-17% -$142K 0.02% 660
2022
Q2
$814K Buy
8,899
+6,916
+349% +$652K 0.02% 635
2022
Q1
$214K Buy
+1,983
New +$191K 0.01% 965
2021
Q4
Sell
-7,886
Closed -$892K 1339
2021
Q3
$892K Sell
7,886
-714
-8% -$77K 0.03% 410
2021
Q2
$767K Buy
+8,600
New +$805K 0.02% 608
2020
Q4
Sell
-4,800
Closed -$346K 738
2020
Q3
$346K Buy
+4,800
New +$382K 0.05% 298

Other funds holding EXPO

Ergoteles's EXPO Position: Q2 2023 in Review

Ergoteles sold out of Exponent (EXPO) in Q2 2023, closing a stake of 138,311 shares — an estimated $13.8M sold.

Ergoteles first reported a position in EXPO in Q3 2020 and held it in 8 quarters. The position peaked at $13.8M in Q1 2023. 356 funds tracked by Wall St. Rank hold EXPO as of Q2 2023.

  • Ergoteles reported no remaining Exponent position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 138,311 Exponent shares in Q2 2023, an estimated $13.8M.
  • Ergoteles first reported a position in Exponent in Q3 2020 and held it in 8 quarters.
  • Ergoteles's Exponent position peaked at $13.8M in Q1 2023.
  • 356 funds tracked by Wall St. Rank held Exponent as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.